Favorites Sign in
  1. Home
  2. Companies
  3. Stock Soligenix
Soligenix logo

Soligenix SNGX

$ 0.32 -5.88%
report update icon

Quarterly report 2026-Q3
added 11-06-2026

Country

 usaUSA

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ CAPITAL

Shares

 5.19 M

Market Cap[1]

 $ 1.66 M

EBITDA (LTM)

 $ -9.83 M

P/E (LTM)

 -1.172414

P/S (LTM)

 14.779067

EPS (LTM)

 -0.29

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited
TEVA
 		$ 42.54 -1.0 % $ 48.7 B NYSE israelIsrael
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
 		$ 2.99 -3.55 % $ 2.03 M Nasdaq Global Select Market chinaChina
Spruce Biosciences Spruce Biosciences
SPRB
 		$ 46.36 -6.04 % $ 35.5 M Nasdaq Global Select Market usaUSA
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
TAK
 		$ 20.9 -0.9 % $ 33 B NYSE japanJapan
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
 		$ 28.77 4.15 % $ 1.62 B Nasdaq Global Select Market,SPB usaUSA
Galapagos NV Galapagos NV
GLPG
 		- - $ 1.83 B Nasdaq Global Select Market belgiumBelgium
Savara Savara
SVRA
 		$ 4.92 -2.57 % $ 1.09 B Nasdaq Global Select Market usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
 		- -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
 		- - $ 2.91 B Nasdaq Global Select Market usaUSA
TG Therapeutics TG Therapeutics
TGTX
 		$ 64.27 1.4 % $ 9.28 B Nasdaq Capital Market usaUSA
Aphria Inc. Aphria Inc.
APHA
 		- -0.45 % $ 4.87 B Nasdaq Global Select Market canadaCanada
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
 		- -0.90 % $ 104 M Nasdaq Capital Market usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
 		- -6.00 % $ 238 M Nasdaq Global Select Market usaUSA
Trevi Therapeutics Trevi Therapeutics
TRVI
 		$ 14.92 -2.55 % $ 2.01 B Nasdaq Global Market usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
 		- - $ 376 M Nasdaq Global Market usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
 		- 0.38 % $ 12.9 M Nasdaq Global Select Market israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
 		- 2.07 % $ 34.4 M Nasdaq Capital Market usaUSA
Cerecor Inc. Cerecor Inc.
CERC
 		- -1.68 % $ 283 M Nasdaq Capital Market usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
 		- - $ 1.63 B Nasdaq Global Select Market usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
 		- -1.77 % $ 39.2 M Nasdaq Capital Market bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
 		- 0.34 % $ 2.98 B Nasdaq Global Select Market,SPB usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
 		- 1.3 % $ 27.7 M Nasdaq Global Select Market franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
 		- - $ 6.81 B Nasdaq Global Select Market britainBritain
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
 		- - $ 1.7 B Nasdaq Global Select Market usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
 		- - $ 256 M Nasdaq Global Market canadaCanada
argenx SE argenx SE
ARGX
 		$ 972.42 1.05 % $ 59.6 B Nasdaq Global Select Market niderlandNiderland
XBiotech XBiotech
XBIT
 		$ 1.97 3.2 % $ 60.1 M Nasdaq Global Select Market usaUSA
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
 		- -2.54 % $ 57.2 M Nasdaq Global Market usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
 		- -3.18 % $ 58.5 M Nasdaq Global Select Market usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
 		- -2.25 % $ 31.3 M Nasdaq Global Select Market danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
 		- -10.74 % $ 89.9 M Nasdaq Global Select Market usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
 		- - $ 1.77 B Nasdaq Global Select Market usaUSA
Xenetic Biosciences Xenetic Biosciences
XBIO
 		$ 1.76 -2.09 % $ 2.99 M Nasdaq Capital Market usaUSA
Viridian Therapeutics Viridian Therapeutics
VRDN
 		$ 30.86 2.22 % $ 3.14 B Nasdaq Capital Market usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
 		- - $ 2.81 B Nasdaq Global Select Market,SPB usaUSA
Trillium Therapeutics Inc. Trillium Therapeutics Inc.
TRIL
 		- - $ 1.94 B Nasdaq Capital Market canadaCanada
Urovant Sciences Ltd. Urovant Sciences Ltd.
UROV
 		- - $ 532 M Nasdaq Global Select Market britainBritain
Acceleron Pharma Inc. Acceleron Pharma Inc.
XLRN
 		- - $ 10.9 B Nasdaq Global Market,SPB usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
 		- 0.52 % $ 821 M Nasdaq Global Select Market danmarkDanmark
Zogenix, Inc. Zogenix, Inc.
ZGNX
 		- -4.97 % $ 664 M Nasdaq Global Market,SPB usaUSA
Yunhong International Yunhong International
ZGYH
 		- 0.10 % $ 92.2 M Nasdaq Capital Market chinaChina
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
 		- -7.58 % $ 264 M Nasdaq Global Select Market usaUSA
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
 		$ 41.4 2.35 % $ 3.28 B Nasdaq Global Select Market canadaCanada
Leap Therapeutics Leap Therapeutics
LPTX
 		- 368.57 % $ 41.9 M Nasdaq Global Market usaUSA
Zymeworks Zymeworks
ZYME
 		$ 31.45 2.08 % $ 1.62 B NYSE canadaCanada
Adial Pharmaceuticals Adial Pharmaceuticals
ADIL
 		$ 3.15 -35.42 % $ 2.11 M Nasdaq Capital Market usaUSA
ADMA Biologics ADMA Biologics
ADMA
 		$ 12.67 -0.98 % $ 3.02 B Nasdaq Global Market usaUSA
Cortexyme Cortexyme
CRTX
 		- -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Burford Capital Limited Burford Capital Limited
BUR
 		$ 3.66 -1.35 % $ 802 M NYSE britainBritain

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.